Hypnoanalgesia for Dermatological Surgery in Children
Launched by COMPLEJO HOSPITALARIO DE TOLEDO · Jan 10, 2021
Trial Information
Current as of July 02, 2025
Completed
Keywords
ClinConnect Summary
In this clinical trial, pediatric patients scheduled for removal of benign skin lesions in a single center willbe randomised to receive hypnosis (intervention group) or attention-distracting techniques (control group). Endpoints will be the sedative dose (propofol) during surgery, and the need for analgesia (paracetamol and others) immediately after surgery (recovery) and after 24 hours. Randomization will be systematic in blocks depending on the day the surgery is programmed. Hypnosis will be delivered by an experienced anesthesist trained in the technique. Patients and families will be in...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. A class I or II of anaesthetic risk according to the American Society of Anesthesiologists,
- • 2. to be in a percentile between P3 and P97 in weight and height,
- • 3. without known drug allergies, and
- • 4. having fasted 6 hours for solids and 2 hours for water.
- Exclusion Criteria:
- • 1. Children with diagnosed mental retardation or attention deficit,
- • 2. behavioural disorders,
- • 3. previous treatment with hypnosis,
- • 4. history of neurological pathology or psychomotor retardation,
- • 5. previous pain-related pathology,
- • 6. obstructive sleep apnoea syndrome (OSAS)
About Complejo Hospitalario De Toledo
Complejo Hospitalario de Toledo is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Located in Toledo, Spain, this comprehensive hospital complex integrates cutting-edge technology with a multidisciplinary approach, facilitating a wide range of clinical studies across various therapeutic areas. Committed to ethical standards and patient safety, the institution collaborates with academic and industry partners to foster scientific discovery and enhance the quality of care. With a focus on translating research findings into clinical practice, Complejo Hospitalario de Toledo plays a vital role in the advancement of medical knowledge and the development of new treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toledo, , Spain
Patients applied
Trial Officials
Juana Maria PELAEZ PEREZ, PH
Principal Investigator
Complejo Hospitalario Toledo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials